.Novo Nordisk is actually continuing its own press into genetic medications, accepting compensate Na...
.Innovent Biologics has made the case that its own checkpoint inhibitor-cytokine combination healthy...
.A period 3 trial of Daiichi Sankyo and Merck & Co.'s HER3-directed antibody-drug conjugate (ADC)...
.5 months after Rakovina Rehabs rotated toward artificial intelligence, the cancer-focused biotech h...
.Ascendis Pharma has emerged as a potential risk to BioMarin's Voxzogo, stating stage 3 development ...
.Though Alkeus Pharmaceuticals' oral eye disease asset neglected to dramatically minimize geographic...
.With a trio of biotechs attacking the Nasdaq on Friday, it was actually very easy to miss a smaller...
.Invulnerable checkpoint inhibitors are actually the superheroes of cancer therapy. Medications like...
.Welcome to recently's Chutes & Ladders, our roundup of substantial leadership hirings, firings a...
.Regeneron is back along with lasting follow-up for its own LAG-3 inhibitor and PD-1 prevention comb...